NASDAQ | ETF
Under normal circumstances, the fund seeks to achieve its investment objective by investing at least 80% of its assets in securities in the index.
The index provider constructs the index in accordance with a rules-based methodology that selects 50 companies from the S-NetworkU. S.
Equity Large/Mid-Cap 1000 Index.
The fund generally seeks to track the returns of the index before fees and expenses by employing a replication strategy that seeks to hold all the stocks in the index.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| APP | Applovin Corp | Technology | Software - Application | 4.56% |
| CVX | Chevron Corp | Energy | Oil & Gas Integrated | 4.24% |
| QCOM | Qualcomm Incorporated | Technology | Semiconductors | 3.65% |
| DVN | Devon Energy Corporation | Energy | Oil & Gas E&P | 3.62% |
| UNH | UnitedHealth Group Incorporated | Healthcare | Healthcare Plans | 3.51% |
| VST | Vistra Energy Corp | Utilities | Utilities - Independent Power Producers | 3.36% |
| CI | Cigna Corp | Healthcare | Healthcare Plans | 3.31% |
| OMC | Omnicom Group Inc | Communication Services | Advertising Agencies | 3.31% |
| ACN | Accenture plc | Technology | Information Technology Services | 3.30% |
| CRM | Salesforce.com Inc | Technology | Software - Application | 3.24% |
| ABBV | AbbVie Inc | Healthcare | Drug Manufacturers - General | 3.20% |
| CSCO | Cisco Systems Inc | Technology | Communication Equipment | 3.16% |
| DELL | Dell Technologies Inc | Technology | Computer Hardware | 3.14% |
| CVS | CVS Health Corp | Healthcare | Healthcare Plans | 3.08% |
| ADBE | Adobe Systems Incorporated | Technology | Software - Application | 3.06% |
| GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 3.04% |
| XOM | Exxon Mobil Corp | Energy | Oil & Gas Integrated | 3.03% |
| SNDK | Sandisk Corp | Technology | Computer Hardware | 3.01% |
| VLO | Valero Energy Corporation | Energy | Oil & Gas Refining & Marketing | 3.00% |
| BMY | Bristol-Myers Squibb Company | Healthcare | Drug Manufacturers - General | 2.96% |